UPDATE 1-U.S. FDA panel to vote whether diabetes drug cuts cardiac death

June 24 (Reuters) - An advisory panel to the U.S. Food and Drug Administration will be asked to vote next week on whether a diabetes drug made by Eli Lilly & Co and Boehringer Ingelheim cuts the risk of cardiovascular death, according to documents posted on the agency's website on Friday.